Summary | |
---|---|
Symbol | RGPD3 |
Name | RANBP2-like and GRIP domain containing 3 |
Aliases | RanBP2-like and GRIP domain-containing protein 3 |
Chromosomal Location | 2q12.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | - |
Domain |
PF01465 GRIP domain PF16704 Rab binding domain PF00638 RanBP1 domain |
Function |
- |
Biological Process |
GO:0000042 protein targeting to Golgi GO:0000301 retrograde transport, vesicle recycling within Golgi GO:0006891 intra-Golgi vesicle-mediated transport GO:0034067 protein localization to Golgi apparatus GO:0048193 Golgi vesicle transport GO:0072600 establishment of protein localization to Golgi |
Molecular Function | - |
Cellular Component | - |
KEGG |
hsa03013 RNA transport |
Reactome | - |
Summary | |
---|---|
Symbol | RGPD3 |
Name | RANBP2-like and GRIP domain containing 3 |
Aliases | RanBP2-like and GRIP domain-containing protein 3 |
Chromosomal Location | 2q12.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between RGPD3 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | RGPD3 |
Name | RANBP2-like and GRIP domain containing 3 |
Aliases | RanBP2-like and GRIP domain-containing protein 3 |
Chromosomal Location | 2q12.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of RGPD3 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | RGPD3 |
Name | RANBP2-like and GRIP domain containing 3 |
Aliases | RanBP2-like and GRIP domain-containing protein 3 |
Chromosomal Location | 2q12.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of RGPD3 in various data sets.
|
Points in the above scatter plot represent the mutation difference of RGPD3 in various data sets.
|
Summary | |
---|---|
Symbol | RGPD3 |
Name | RANBP2-like and GRIP domain containing 3 |
Aliases | RanBP2-like and GRIP domain-containing protein 3 |
Chromosomal Location | 2q12.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of RGPD3. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | RGPD3 |
Name | RANBP2-like and GRIP domain containing 3 |
Aliases | RanBP2-like and GRIP domain-containing protein 3 |
Chromosomal Location | 2q12.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of RGPD3. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by RGPD3. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | RGPD3 |
Name | RANBP2-like and GRIP domain containing 3 |
Aliases | RanBP2-like and GRIP domain-containing protein 3 |
Chromosomal Location | 2q12.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of RGPD3. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | RGPD3 |
Name | RANBP2-like and GRIP domain containing 3 |
Aliases | RanBP2-like and GRIP domain-containing protein 3 |
Chromosomal Location | 2q12.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of RGPD3 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | RGPD3 |
Name | RANBP2-like and GRIP domain containing 3 |
Aliases | RanBP2-like and GRIP domain-containing protein 3 |
Chromosomal Location | 2q12.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between RGPD3 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |